Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore the latest advancements in gynecologic cancer biomarker testing and precision medicine approaches in this comprehensive webinar presented by Dr. Gulisa Turashvili, an associate professor and anatomic pathologist specializing in gynecologic and breast pathology at Emory University School of Medicine. Delve into the critical role of prognostic and predictive markers in gynecologic cancers, which account for nearly 40% of all cancer incidence and more than 30% of cancer mortality in women worldwide. Learn about significant recent developments in tumor classification and biomarker testing, including human papillomavirus testing, DNA mismatch repair analysis, HER2 and PD-L1 testing, and homologous recombination testing. Understand how the combination of accurate histopathologic diagnosis and biomarker status ensures timely and optimal therapy for each patient with gynecologic cancer. Discover how these advancements are revolutionizing personalized treatment approaches and improving patient outcomes in the era of precision medicine. This educational session offers valuable insights for pathologists, oncologists, and healthcare professionals involved in gynecologic cancer care, with the opportunity to earn PACE credits upon completion.
